Shruti Bhat PhD, MBA, Lean Six Sigma Black Belt
  • Consulting
  • Workshops
  • Books
  • Blog
  • Case Studies
  • Resources
  • Hall of Fame
  • Contact
  • Free E Book
  • Digital Magazine

Australian Innovation Patent Advantage - Ignore it at Your Potential Peril

2/25/2010

0 Comments

 
Picture
The facts

The Australian patent system has a unique beast called the "innovation patent". Under the Australian patent system it is possible to obtain both standard patents and innovation patents. Under the innovation patent system, while the term is only eight years, there is no test for obviousness, but rather a test for "innovative step". Further, in certain circumstances, it is possible to file innovation patents from standard patents and vice versa.

The lack of an obviousness test provides a great opportunity for patentees to take advantage of our innovation patent as a powerful strategic property in its own right and/or to maximise their advantage during litigation. Such was the case in Dura-Post (Aust) Pty Ltd v Delnorth Pty Ltd [2009] FCAFC 81, where the Full Federal Court recently decided to uphold a trial judge's decision that an innovation patent was not subject to an obviousness test, but rather to the substantially weaker "innovative step" test being something peculiar to Australian jurisprudence.

In the Dura-Post case, relating to the simple subject matter of elastically-deformable road-side posts, the patentee had filed multiple divisional innovation patents from a standard patent and successfully sued on the innovation patents. The successful innovation patent claims each defined a new, but arguably non-inventive, combination of known features. However, the Court concluded, based on evidence, that in each case the claimed difference over the prior art, while small, did provide a substantial or "real" contribution to the working of the invention and as such passed the threshold test.

The implications and recommendations

The absence of an obviousness test allows applicants to potentially obtain protection for more marginal developments and/or obtain broader rights for an invention in Australia than would be possible in nearly all other jurisdictions. As such, we would encourage potential applicants to consider innovation patents as an adjunct to a standard patent application in order to obtain a fast-to-grant right with potentially broader claims. They should also be considered as an adjunct or alternative for developments that would normally at best be protected via the useful, but limited, registered designs regime. Importantly, many applicants are already doing this. It is undoubtedly preferable to be the holder of innovation patents in your particular IP space, than trying to operate around competitors' rights which may prove to be unexpectedly broad and difficult to successfully challenge.

Innovation patents proceed to "grant" with only basic formalities review. They need not be examined substantively unless and until the patentee wishes to establish enforceable rights. In this way, they can be both powerful and flexible, as it is clear from this latest case that minor points of distinction disclosed within the specification may be sufficient to establish patentable rights.

For the same reasons, it is difficult to accurately predict the potential scope of granted but unexamined innovation patents of third parties. This arguably provides an added incentive for applicants to attempt to dominate particular market sectors through innovation patents.

However, it is worth noting that the innovation patent regime appears to be at odds with one of IP Australia's stated goals, of aligning Australian patentability standards with those of other major jurisdictions such as Europe and the US. Such policy considerations may give rise to a substantive review or revision of the regime in due course, although any resultant changes would almost certainly not have retrospective effect.

Meanwhile, based on the law as it presently stands, a good option is to take full advantage of the significant strategic and commercial benefits that innovation patents currently provide. Your competitors may already be doing just that!

Disclaimer- The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances. 

Http://www.drshrutibhat.com
Expert at leading Pharmaceutical R&D.
Translates innovative concepts to PROFITS.
Do you have questions for the author? 
 

0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    New Book Released!

    kaizen for leaders, continuous process improvement tool to increase profit and organizational excellence by shruti bhat

    Shruti's books...

    Picture
    Picture
    shruti bhat, business process management, continuous improvement
    Picture
    kaizen for pharmaceutcials, medical devices and biotech industry book by Dr Shruti Bhat
    kaizen, shruti bhat, continuous improvement, quality, operations management

    New Online Course Released!

    ​Kaizen Leader Certification
    ​Masterclass
    kaizen leader masterclass for pharmaceuticals, shruti bhat
    Picture

    Shruti Bhat
    PhD Tech MBA
    Certified Lean Six Sigma Black Belt

    Shruti is a Global Business Excellence and Continuous Improvement Leader.

    Shruti is true Thought Leader with over 10 years of demonstrated accomplishments, industry awards, certifications, books, patents and several publications in peer reviewed journals.

    Shruti is appreciated for her knowledge, integrity, innovation, and collaborative team approach with effective mentoring as her organizational leadership style.
    About Shruti Bhat

    Blog Categories

    All
    3D Printing
    5S
    Artificial Intelligence
    Biotechnology
    Books
    Case Studies
    CMMI
    Continuous Improvement
    Cosmetics & Personal Products
    Design Thinking
    Drug Discovery
    Food Industry
    Hall Of Fame
    Health Care
    Innovation
    ISO
    Just In Time
    Kaizen
    LEAN
    Lean Six Sigma
    Manufacturing
    Medical Apps
    Medical Devices
    Motivational Cards
    Nanotechnology
    Novel Drug Delivery
    Operations
    Orphan Drugs
    Packaging & Logistics
    Patents
    Pharma Research
    Precision Medicine
    Process Improvement
    Product Development
    Productivity Improvement
    QbD
    Quality By Design
    Quality- By-Design
    Quality Management
    Rare Diseases
    Robotics
    Service Industry
    Six Sigma
    Targeted Drug Delivery
    TQM
    Videos
    Voice Of Customer
    Workshops

    Attention Readers!

    The information posted here (not limited to blog, website, podcasts, videos, Inno-ideas slides, slide-shows, whitepapers and other downloadable 'free' resources) is Copyright protected, 'for review and reference' purpose only. Not to be copied, sold, distributed or used without prior authorization by Dr. Shruti U Bhat. Any instance(s) found to the contrary would be construed as copyright violation, illegal, plagiarism and/or could be subject to legal proceedings.

    For additional details, refer our
    Terms & Conditions for site usage.

    More Books...

    fast read books, business management books, health and wellness books, spiritual guidance books, best online book store

    Health & Wellness

    Picture


    Kaizen Certification Online Courses

    kaizen leader certification, kaizen champion certification, kaizen orientation training, process efficiency expert certification, kaizen tools, kaizen leader for pharmaceuticals, kaizen certification, kaizen training, shruti bhat
© Copyright 1992- 2019 Dr. Shruti Bhat ALL RIGHTS RESERVED.
See Terms and Conditions on this site usage.
SHRUTI BHAT, CONTACT
Click to connect.
Created by Macro2Micro Media